Current Evidence and Future Perspectives of Immune-Checkpoint Inhibitors in Unresectable Malignant Pleural Mesothelioma

Journal for ImmunoTherapy of Cancer - United Kingdom
doi 10.1136/jitc-2019-000461
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Immune Checkpoint Inhibitors in Malignant Pleural Mesothelioma: Promises and Challenges

Expert Review of Anticancer Therapy
OncologyPharmacology
2016English

P2.06-25 Combined Immune Checkpoint Blockade in Malignant Pleural Mesothelioma: In Vivo Validation of in Vitro Results

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Malignant Pleural Mesothelioma

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
2009English

Heterogeneity in Malignant Pleural Mesothelioma

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2018English

Malignant Pleural Mesothelioma: History, Controversy and Future of a Manmade Epidemic

European Respiratory Review
PulmonaryRespiratory Medicine
2015English

Chemotherapy of Malignant Pleural Mesothelioma.

Japanese Journal of Lung Cancer
OncologyRespiratory MedicinePulmonary
1990English

Current Landscape and Future Directions of Biomarkers for Predicting Responses to Immune Checkpoint Inhibitors

Cancer Management and Research
Oncology
2018English

Disseminated Pleural Siliconoma Mimicking Malignant Pleural Mesothelioma

Annals of Thoracic Surgery
Respiratory MedicinePulmonaryCardiovascular MedicineSurgeryCardiology
2015English

Volumetric Assessment in Malignant Pleural Mesothelioma

Annals of Translational Medicine
Medicine
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy